申请人:Schering Aktiengeseellschaft
公开号:US06288065B1
公开(公告)日:2001-09-11
The disclosure relates to quinoxaline derivates of Formula I
wherein
R1, R4, R5, R6, R7 and R8 are defined in the disclosure, as well as their production and use in medicinal agents.
本公开涉及公式I中的喹喔啉衍生物,其中R1、R4、R5、R6、R7和R8在本公开中有定义,以及它们在药物制剂中的生产和使用。